It is now widely accepted that recognition of peptide/MHC complexes on antigen presenting cells (APCs) is not sufficient for most aspects of CD4 T-cell function, and that additional interactions between T-cell co-receptors and APC accessory molecules are required for optimal cell growth, cytokine secretion, and induction of effector function. The majority of studies of costimulation have focused on the interactions between CD28 and B7, and CD40L and CD40, leading to the current concept that these are the critical molecules involved in T-cell responses. However, work by the investigator has shown that other receptor/ligand pairs can function as costimulators, for example LFA-1/ICAM-1. The goal of the current application is evaluation of the possibility that the Ox-40/Ox-40L and 4-1BB/4-1BBL interactions, which are expressed on T-cells and APC after activation, transduce critical costimulatory signals late in the response. In vitro experiments will explore the expression of Ox-40 and 4-1BB on naive, effector, and memory T-cells derived from TCR transgenic mice following stimulation with L cells expressing Ox-40L, 4-1BBL, B7, and/or ICAM-1, or physiological APC such as B-cells or dendritic cells. T-cell proliferation, Th1 and Th2 lymphokine production, and rescue from apoptosis will be measured. The role of the Ox-40/Ox-40L and 4-1BB/4-1BBL interactions in vivo in primary and secondary responses will be tested in normal mice and adoptive transfer recipients. Finally, the role of Ox-40/Ox-40L and 4-1BB/4-1BBL interactions in collagen-induced arthritis will be tested.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI042944-02
Application #
2887716
Study Section
Immunological Sciences Study Section (IMS)
Program Officer
Ridge, John P
Project Start
1998-04-01
Project End
2002-03-31
Budget Start
1999-04-01
Budget End
2000-03-31
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
La Jolla Institute
Department
Type
DUNS #
603880287
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Eun, So-Young; Lee, Seung-Woo; Xu, Yanfei et al. (2015) 4-1BB ligand signaling to T cells limits T cell activation. J Immunol 194:134-41
Madireddi, Shravan; Eun, So-Young; Lee, Seung-Woo et al. (2014) Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies. J Exp Med 211:1433-48
Ma, Jianhui; Bang, Bo-Ram; Lu, Jiawei et al. (2013) The TNF family member 4-1BBL sustains inflammation by interacting with TLR signaling components during late-phase activation. Sci Signal 6:ra87
Bae, Jun-Sang; Choi, Joong-Kook; Moon, Ji-Hoi et al. (2012) Novel transmembrane protein 126A (TMEM126A) couples with CD137L reverse signals in myeloid cells. Cell Signal 24:2227-36
Lee, Seung-Woo; Park, Yunji; Eun, So-Young et al. (2012) Cutting edge: 4-1BB controls regulatory activity in dendritic cells through promoting optimal expression of retinal dehydrogenase. J Immunol 189:2697-701
Zhao, Yuan; Croft, Michael (2012) Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells. Immunol Lett 141:220-6
Lee, Seung-Woo; Choi, Heonsik; Eun, So-Young et al. (2011) Nitric oxide modulates TGF-beta-directive signals to suppress Foxp3+ regulatory T cell differentiation and potentiate Th1 development. J Immunol 186:6972-80
Hsieh, En Hui; Fernandez, Xiomara; Wang, Jing et al. (2010) CD137 is required for M cell functional maturation but not lineage commitment. Am J Pathol 177:666-76
Humphreys, Ian R; Lee, Seung-Woo; Jones, Morgan et al. (2010) Biphasic role of 4-1BB in the regulation of mouse cytomegalovirus-specific CD8(+) T cells. Eur J Immunol 40:2762-8
Salek-Ardakani, Shahram; Croft, Michael (2010) Tumor necrosis factor receptor/tumor necrosis factor family members in antiviral CD8 T-cell immunity. J Interferon Cytokine Res 30:205-18

Showing the most recent 10 out of 23 publications